- Home
- GSRT vs ARCT Comparison
GSRT vs ARCT Comparison
Compare GSRT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSRT
- ARCT
- Stock Information
- Founded
- GSRT 2023
- ARCT 2013
- Country
- GSRT United States
- ARCT United States
- Employees
- GSRT N/A
- ARCT N/A
- Industry
- GSRT
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- GSRT
- ARCT Health Care
- Exchange
- GSRT Nasdaq
- ARCT Nasdaq
- Market Cap
- GSRT 324.1M
- ARCT 373.7M
- IPO Year
- GSRT 2024
- ARCT N/A
- Fundamental
- Price
- GSRT $10.76
- ARCT $14.38
- Analyst Decision
- GSRT
- ARCT Strong Buy
- Analyst Count
- GSRT 0
- ARCT 8
- Target Price
- GSRT N/A
- ARCT $52.83
- AVG Volume (30 Days)
- GSRT 833.5K
- ARCT 384.9K
- Earning Date
- GSRT 01-01-0001
- ARCT 08-04-2025
- Dividend Yield
- GSRT N/A
- ARCT N/A
- EPS Growth
- GSRT N/A
- ARCT N/A
- EPS
- GSRT 0.14
- ARCT N/A
- Revenue
- GSRT N/A
- ARCT $143,680,000.00
- Revenue This Year
- GSRT N/A
- ARCT N/A
- Revenue Next Year
- GSRT N/A
- ARCT $34.08
- P/E Ratio
- GSRT $77.75
- ARCT N/A
- Revenue Growth
- GSRT N/A
- ARCT 15.38
- 52 Week Low
- GSRT $9.86
- ARCT $8.04
- 52 Week High
- GSRT $11.49
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- GSRT N/A
- ARCT 55.17
- Support Level
- GSRT N/A
- ARCT $12.75
- Resistance Level
- GSRT N/A
- ARCT $15.83
- Average True Range (ATR)
- GSRT 0.00
- ARCT 0.85
- MACD
- GSRT 0.00
- ARCT 0.08
- Stochastic Oscillator
- GSRT 0.00
- ARCT 52.92
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.